The following development organizations are recipients of Expansion Solutions Magazine’s 2010 Awards of Excellence in the *** Biotech*** industry category. These awards recognize organizations who have demonstrated exceptional progress and potential in the development of their areas -- by successfully recruiting, retaining and growing businesses. The winners below are listed in alphabetical order and are reflective of our top 5 selections.
* * * * * * * * * * * * * * * *
Austin Chamber of Commerce
An active partnership exists between academia, the city and state government, and the life sciences community to grow the life sciences sector in Austin. BioAustin, an Austin Chamber initiative, is focused on fostering an environment that attracts and supports bio-related companies, researchers and entrepreneurs. The University of Texas and the City of Austin fund the Austin Technology Incubator that works with early stage companies to increase their rates of success and decrease their time to capital and markets. Ut Austin’s Office of Technology Commercialization serves as a bridge between the research community and the University and commercialization partners, ensuring smooth and fast transfer of intellectual property created at the University. And, the Texas Life Sciences Commercialization Center provides assistance and shared resources to post-incubation companies.
Austin is home to both the University of Texas at Austin and the University of Texas System. In the Austin metro, you'll find a combined enrollment of 118,000 students in four year and community colleges. This provides an ample supply of well-educated workers to area employers. The student population within 100 miles of Austin exceeds 330,000, providing one of the world's strongest talent pools.
As a world-class research institution, the University of Texas at Austin (UT) has annual research expenditures of more than $497 million. The University consistently ranks in the top 10 for the number of science and engineering doctoral degrees and is the fourth most patent-earning university in the country. UT Austin's world-class programs include bioengineering, nanotechnology, bioinformatics and pharmaceutical research - in fact the College of Pharmacy is one of the premier institutions of pharmaceutical education and research in the country. UT Austin is home to more than 100 organized research units including several of which will impact Austin's future in bioscience technology development and commercialization.
Austin's attractiveness as a place to live and work is a huge draw for the life sciences industry. Austin is a metropolitan region of 1.6 million people with great diversity in life sciences, including more than 100 companies in the areas of research, diagnostics, pharmaceuticals, medical device and other related industries. Overall, the tech sector employs more than 100,000 or 18% of the private sector workforce.
Metro Atlanta Chamber of Commerce
Atlanta has much to offer the biotech community. They have top research universities which work collaboratively with the business community. They have global airport access and a strategic location. They have strengths in pharmaceuticals, medical devices, agri-bio and have been ranked nationally in nanomedicine and has the world’s foremost eminent scholar in vaccine development. The city also benefits from the presence of the Centers of Disease Control (CDC), the American Cancer Society and the Arthritis Foundation. Atlanta’s bioscience community was ranked #6 by Ernst & Young in 2006 and has grown substantially since that time.
Last year, four of Atlanta's leading health care and research organizations announced the creation of a medical research "innovation center" to speed to market next generation medical devices and technology. Georgia Tech, St. Joseph's Translational Research Institute, Piedmont Healthcare and the Georgia Research Alliance put up $100,000 to launch the Global Center for Medical Innovation (GCMI). The center will be housed at Technology Enterprise Park, alongside Georgia Tech.
In July 2010, GCMI was awarded $2.6 million to build and equip a prototyping design and development facility. The center’s initial focus will be on cardiology, orthopedics and pediatrics.
The center is expected to generate $72 million in new investments and create or save 161 jobs. The center will receive $1.3 million from the Economic Development Administration, part of the U.S. Department of Commerce, according to a statement. That will be matched by $1.3 million from the Georgia Research Alliance, a public-private organization that supports development of the technology industry in Georgia.
In addition to its renowned Vaccine Center, Emory University has established a drug discovery center. The Emory Institute for Drug Discovery will carry out early-stage discovery and pre-clinical drug research aimed at developing small-molecule therapeutics and training new researchers.
The Seattle region is a world-class center for Life Sciences and has been ranked as the 5th largest Life Science cluster in the United States in a recent Milken Institute study. This expanding cluster has a wealth of talented people and incredible institutions while being unique in its’ collaborative nature and ability to attract and keep world-class talent.
The Puget Sound region boasts one of the most significant concentrations of life sciences companies in the United States. In King County, for instance, there are 160 life sciences companies that employ more than 15,000 people.
Many of these companies grew out of cutting-edge research conducted at the numerous public and private research institutions based in the region, such as the University of Washington, Fred Hutchinson Cancer Research Center and Seattle Biomedical Research Institute—to name just a few.
Efforts are underway across the region and state to support the development of this critical sector. Examples include the redevelopment of Seattle’s South Lake Union neighborhood as a center for biotechnology and research, and the Life Sciences Discovery Fund’s annual Grant Competitions. In 2009, the Fund announced the addition of a new commercialized grant program designed to promote the commercialization of new promising technologies.
Research Triangle Regional Partnership
RDU International Airport, NC
A study released by the Battelle Memorial Institute earlier this spring cited North Carolina's Research Triangle Region as a “National Life Sciences Leader”. The study benchmarked how U.S. states and regions are faring in their efforts to attract companies and quality jobs in an increasingly competitive national and international environment during a challenging economic downturn.
Among the Battelle report's key findings:
*Raleigh-Cary and Durham-Chapel Hill metropolitan statistical areas (MSAs) accounted for 10,816 of the state's 18,789 drug and pharmaceutical jobs in 2008. Those jobs paid an average annual wage of $74,829 and each job generated an additional 4.6 jobs for the state and regional economy.
*Raleigh-Cary and Durham-Chapel Hill 2008 MSAs accounted for 12,988 research-and-testing company jobs at an average $75,829 annual wage in 2008. Those jobs generated an additional 2.6 jobs each for the state and region.
*Durham-Chapel Hill ranked first among mid-sized 2008 MSAs (those with employment of 75,000-250,000) for jobs in two core employment concentration sub-sectors of the nation's life sciences industry: research, testing and medical laboratories jobs (8,270) and drugs and pharmaceuticals jobs (6,755).
*Raleigh-Cary ranked 4th in drugs and pharmaceuticals jobs (3,331) and 11th in research, testing and medical laboratories jobs (3,718) among large MSAs with total private employment of greater than 250,000.
Among the state and region's competitive assets for life sciences investment cited in the report were:
*National Institutes of Health awards of $6.49 billion to North Carolina biomedical research centers during 2004-2009.
*579 U.S. Food and Drug Administration clinical trials for the 10 largest disease categories conducted in the state during 2009.
*2,308 bioscience-related patents issued in North Carolina during 2004-2009.
"Life sciences is a key driver of our region's economy," Hayes said. "We remain focused on taking the steps necessary to help our existing life sciences companies remain competitive and to attract new investment and jobs."
San Diego Regional Economic Development Corporation
San Diego, CA
San Diego is home to more than 550 biomedical companies. Corporations located there include: Amylin Pharmaceuticals, Biogen Idec, Gen-Probe, Genentech, Johnson & Johnson, Life Technologies, and Pfizer. The city is home to 21 Nobel Laureates in the sciences. Local universities and research institutions have spun off nearly 200 biotech firms. The biotech cluster in San Diego employs an estimated 40,000 people and has a $9.2 billion annual impact on the local economy. In 2009, San Diego companies and research institutions received more than $1.2 billion in research funding from the National Institutes of Health and National Science Foundation.
40% of San Diego’s adult population has a bachelor’s degree or higher. And many get to work at world-renowned universities and research institutes such as The Burnham Institute, Salk Institute, Scripps Research Institute, and UCSD. San Diego is part of a larger mega-region adjacent to Mexico and Imperial County and well positioned for access to Asia and other markets. The mega-region’s collective assets provide businesses the opportunity to leverage diverse resources in an increasingly global marketplace.
Strong industry groups such as AeA, BIOCOM, CommNexus, CONNECT, and San Diego Software Industry Council provide excellent networking and collaboration opportunities in San Diego.